Medite Cancer Diagnostics, Inc.
MDIT
$0.00
$0.000.00%
| 09/30/2018 | 06/30/2018 | 03/31/2018 | 12/31/2017 | 09/30/2017 | |
|---|---|---|---|---|---|
| Net Income | -- | -6.20M | -7.26M | -6.81M | -5.22M |
| Total Depreciation and Amortization | -- | 329.00K | 315.00K | 293.00K | 273.00K |
| Total Amortization of Deferred Charges | -- | 547.00K | 311.00K | 134.00K | -97.00K |
| Total Other Non-Cash Items | -- | 561.00K | 681.00K | 927.00K | 1.27M |
| Change in Net Operating Assets | -- | -74.00K | 1.39M | 1.89M | 1.96M |
| Cash from Operations | -- | -4.83M | -4.57M | -3.57M | -1.81M |
| Capital Expenditure | -- | -111.00K | -120.00K | -134.00K | -133.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -28.00K |
| Cash from Investing | -- | -111.00K | -120.00K | -134.00K | -161.00K |
| Total Debt Issued | -- | 7.38M | 6.44M | 4.99M | 4.64M |
| Total Debt Repaid | -- | -3.18M | -3.29M | -3.45M | -2.97M |
| Issuance of Common Stock | -- | 506.00K | 1.43M | 2.53M | 2.78M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -211.00K | -211.00K | -211.00K | -30.90K |
| Cash from Financing | -- | 4.49M | 4.37M | 3.86M | 4.42M |
| Foreign Exchange rate Adjustments | -- | 98.00K | 267.00K | 203.00K | -441.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -352.00K | -46.00K | 358.00K | 2.02M |
